Novozymes

About

Novozymes is the world leader in bioinnovation.

Bagsværd,Hovedstaden,Denmark
5001 - 10000
https://www.novozymes.com/en#

Highlights

Details

Last Funding Type: IPO
Industries: Biotechnology,Innovation Management
Founded date: Jan 1, 2000
Number Of Employee: 5001 - 10000
Operating Status: Active
Stock Symbol: cph:NZYM-B
Legal Name: Novozymes A/S

Novozymes is a world leader in bioinnovation. Novozymes works with its partners to innovate new solutions and rethink industries around the world. Novozymes' industrial enzymes, microorganisms, biopolymers, and other proteins allow its customers to achieve more efficient use of raw materials, reduce energy consumption, replace traditional chemicals with more sustainable alternatives, and offer higher-quality products. Novozymes rethinks everyday products every day.

Funding Rounds

Number of Funding Rounds

Total Funding Amount

1

—

Novozymes has raised a total of — in funding over 2 rounds. Their latest funding was raised on Jun 28, 2002 from a IPO round.

Announced Date	Round	Money Raised	Number of Investors	Lead Investors	Post Valuation
Jun 28, 2002	IPO	—	—	—	—	Detail

Investments

Number of Investments

Number of Lead Investments

3

0

Novozymes has made 3 investments. Their most recent investment was on Dec 9, 2018, when Plant Response raised $6.90M.

Date Company Name	Round	Money Raised	Industry	Lead Investor
Dec 9, 2018 Plant Response	Series B	$6.90M	Agriculture	—
Nov 26, 2015 Plant Response	Series A	$6.60M	Agriculture	—
Nov 1, 2014 AgBiome	Series Unknown	$17.50M	Agriculture	—

Employee Profiles

Number of Employee Profiles

23

Novozymes has 23 current employee profiles, including Board member David A. Hogsett

Board member

Board member

Executive

Board member

Executive

Exits

Novozymes has had 1 exits. Novozymes most notable exits include Plant Response

Date	Company Name	Exit Type	Industry
Feb 25, 2022	Plant Response	M&A	Agriculture	Detail

Acquisition

Novozymes has acquired 16 organizations. Their most recent acquisition was Sybron Biochemicals on Jul 1, 2001. They acquired Sybron Biochemicals for 0.

Date Company Name	Industry	Acquisition Type	Price
Jul 1, 2001 Sybron Biochemicals	Biotechnology	acquisition	—	Detail
Feb 6, 2006 Qingdao Huayuan Fine Bio-Products	Biotechnology	acquisition	—	Detail
Sep 19, 2006 Delta Biotechnology	Biotechnology	acquisition	—	Detail
Oct 2, 2006 Earth BioSciences	Biotechnology	acquisition	—	Detail
Oct 31, 2007 Philom Bios	Biotechnology	acquisition	—	Detail